IP Library › Granted Patent US 11,433,151
Granted Patent B2
US 11,433,151 · App. 17/075,138 · Granted Sep 6, 2022

Microbe inactivation processing method and cell activation processing method

Inventor: Tatsushi Igarashi (Tokyo, JP)
Assignee: Ushio Denki Kabushiki Kaisha
A61L2/10G02B5/208A61L2202/14
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,433,151
App. No.
17/075,138
Granted
Sep 6, 2022
Kind
B2
Abstract

Disclosed are a microbe inactivation processing method that can perform inactivation processing of microbes, while damage to human body cells is prevented or inhibited, with an efficient use of light emitted from a light source and the obtainment of a large effective irradiation area. Also provided are a cell activation processing method that can reliably activate target cells with high efficiency. The microbe inactivation processing method includes: a step of applying light emitted from a light source through an optical filter, with the light source configured to emit light having a wavelength within a wavelength range of 190 nm to 237 nm, in order to perform inactivation processing of a target microbe. When the light emitted from the light source is incident at an incident angle of 0°, the optical filter transmits at least a part of ultraviolet light having a wavelength within a range of not lower than 190 nm and not more than 230 nm, and transmits at least a part of ultraviolet light having a wavelength within a range of more than 230 nm and not more than 237 nm, and the optical filter blocks transmission of ultraviolet light having a wavelength out of a wavelength range of not lower than 190 nm and not more than 237 nm.

Claims (11)

1. A microbe inactivation processing method comprising:

a step of applying light emitted from a light source through an optical filter onto a human body, with the light source configured to emit light having a wavelength within a wavelength range of 190 nm to 237 nm, in order to perform inactivation processing of a target microbe on the human body, wherein

when the light emitted from the light source is incident on the optical filter at an incident angle of 0°, the optical filter transmits at least a part of ultraviolet light having a wavelength within a range of not lower than 190 nm and not more than 230 nm, and transmits at least a part of ultraviolet light having a wavelength within a range of more than 230 nm and not more than 237 nm, and the optical filter blocks transmission of ultraviolet light having a wavelength outside of a wavelength range of not lower than 190 nm and not more than 237 nm.

2. The microbe inactivation processing method of claim 1 , wherein when the light emitted from the light source is incident on the optical filter at an incident angle of 0°, the optical filter transmits at least a part of ultraviolet light having a wavelength within the range not lower than 190 nm and not more than 230 nm, and transmits at least a part of the ultraviolet light having a wavelength within the range of not lower than 232 nm and not more than 237 nm.

3. The microbe inactivation processing method of claim 2 , wherein cyclobutane pyrimidine is not produced with application of light in the range of not lower than 232 nm and not more than 237 nm.

4. The microbe inactivation processing method of claim 1 , wherein the energy of the applied light is in a range 10 mJ/cm2 to 1000 mJ/cm2.

5. A microbe inactivation processing method comprising:

a step of applying light emitted from a light source through an optical filter onto a human body, with the light source configured to emit the light having a wavelength within a wavelength range of 190 nm to 237 nm, in order to perform inactivation processing of a target microbe on the human body with an energy of 10 mJ/cm2 to 1000 mJ/cm2, wherein

when the light emitted from the light source is incident on the optical filter at an incident angle of 0°, the optical filter transmits at least a part of ultraviolet light having a wavelength within a range of not lower than 190 nm and not more than 230 nm, and transmits at least a part of ultraviolet light having a wavelength within a range of more than 230 nm and not more than 237 nm, and the optical filter blocks transmission of ultraviolet light having a wavelength within wavelength ranges of UV-B and UV-C excluding a wavelength range of not lower than 190 nm and not more than 237 nm.

6. The microbe inactivation processing method of claim 5 , wherein when the light emitted from the light source is incident on the optical filter at an incident angle of 0°, the optical filter transmits at least a part of ultraviolet light having a wavelength within the range not lower than 190 nm and not more than 230 nm, and transmits at least a part of the ultraviolet light having a wavelength within a range of not lower than 232 nm and not more than 237 nm.

7. The microbe inactivation processing method of claim 6 , wherein cyclobutane pyrimidine is not produced with application of light in the range of not lower than 232 nm and not more than 237 nm.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 20, 2020
From: IGARASHI, TATSUSHI
To: USHIO DENKI KABUSHIKI KAISHA
Reel/Frame 054111/0388 →
Priority Claims (1)
JP 2017-251511 · Dec 27, 2017 · national
Continuity (2)
Division 16232571 · Dec 26, 2018
Related Publication 20210030906A1 · Feb 4, 2021
Cited By (1)
US 12,453,791